Vacunas y evidencias

Este blog se ha creado para apoyo de docencia en vacunología

domingo, 13 de marzo de 2011

Retos y estrategias de la prevención del cáncer de cérvix en Atención Primaria. Dra. MJ Álvarez Pasquín

Retos de la prevención del cáncer de cérvix en Atención Primaria. Dra. MJ Álvarez Pasquín

View more presentations from mjalvarezp.

Publicado por MJ en 5:10

Enviar por correo electrónico Escribe un blog Compartir con Twitter Compartir con Facebook Compartir en Pinterest

Etiquetas: cancer de cérvix, cribado, papiloma virus, vacunas

No hay comentarios:

Publicar un comentario

Entrada más reciente Entrada antigua Inicio

Suscribirse a: Enviar comentarios (Atom)

Acto

Jornadas de Actualización semFYC-Novartis Santiago de Compostela
Jornadas de Actualización semFYC-Novartis Madrid

Rebusca en este blog

Páginas web de interés

Webs recomendadas OMS sobre vacunas
Asociación Española de Vacunología
ECDC Centro Europeo para la prevención y el control de la enfermedad
Consejos viajeros CEC
Consejos viajeros MSPS
EMEA Agencia Europea del Medicamento
Fichas técnicas vacunas AEP
Vademecum de vacunas de AEV
Programa de Actividades y de Promoción de la Salud semFYC
Vacunas de la Asociación Española de Pediatría
Immunize organization
Center of Disease Control
OMS vacunación
Cobertura vacunal mundial OMS
Coberturas de vacunación en España MSPS

Archivo del blog

▼ 2011 (23)
- ► diciembre (1)
- ► noviembre (5)
- ▼ marzo (15)
- ► febrero (2)

Entradas populares

Vacunas solidarias

Las noticias (e investigación) en vacunas son de interés permanente en este blog y en Evidencias en Pediatría. Inevitablemente hemos de co...
Compatibilidad de vacunas. situación en un mundo globalizado

Compatibilidad vacunas View more presentations from mjalvarezp
Vademecum de vacunas

Vademecum de vacunas : un recurso útil para localizar las vacunas en nuestro país, sus fichas técnicas y ayudar a resolver dudas
Vacuna como puedas...

...la mejor vacuna, la puesta. El éxito de los programas de vacunación dependen del logro de altas coberturas...luego VACUNA COMO PUEDAS. V...
Nuevas pautas de vacunación de tétanos-difteria

Pautas de vacunación de difteria y tétanos en adultos View more presentations from saludpublicaaragon
¿Puedo contagiarme si estoy vacunado? de Per Ardua ad Astra

Ya son varias las personas a las que he oído preguntarse cómo es posible contagiarse de una enfermedad de la que has sido vacunado: parece i...
Hablemos de las vacunas desde la ciencia y el conocimiento

Hablemos de las vacunas desde la ciencia y el conocimiento
Los movimientos antivacunas en la red y ¿las ayudas online? Valencia 2010 Dra MJ Álvarez Pasquín

Los movimientos antivacunas en la red y ¿las ayudas online? Valencia 2010 Dra MJ Álvarez Pasquín View more
Calendarios vacunales de las Comunidades Autónomas españolas

Calendarios vacunales de las Comunidades Autónomas españolas , ya que desafortunadamente no tenemos un calendario vacunal único
Ensayos con vacunas; conoce la seguridad de cómo se hace

Las vacunas se administran a población sana (en muchos casos a niños) para prevenir la eventual adquisición de una determinada enfermedad. E...

La guerra de las vacunas

Primera parte de la guerra de las vacunas
Segunda parte de la guerra de las vacunas
Tercera parte de la guerra de las vacunas
Cuarta parte de la guerra de las vacunas

Si eres discente de esta charla...

...te pasaremos la información que nos solicites

Los tutores

Javier Gomez
MJ

GRIPE

La vacuna antigripal administrada a gestantes podría disminuir la incidencia de prematuridad y de bajo peso al nacimiento
Case-based reported mortality associated with laboratory-confirmed influenza A(H1N1) 2009 virus infection in the Netherlands: the 2009-2010 pandemic season versus the 2010-2011 influenza season.
Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States.
Pregnant and Recently Pregnant Women's Perceptions about Influenza A Pandemic (H1N1) 2009: Implications for Public Health and Provider Communication.
Influenza A/H1N1v in pregnancy: an investigation of the characteristics and management of affected women and the relationship to pregnancy outcomes for mother and infant.
Informe del Comité de expertos de la OMS sobre la pandemia A H1N1 2009-10
Effectiveness of seasonal 2008-2009, 2009-2010 and pandemic vaccines, to prevent influenza hospitalizations during the autumn 2009 influenza pandemic wave in Castellón, Spain. A test-negative, hospital-based, case-control study.
A 29-Year-Old Woman With Flu-like Symptoms
Estimates of Pandemic Influenza Vaccine Effectiveness in Europe, 2009-2010: Results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) Multicentre Case-Control Study.
Vaccine effectiveness in pandemic influenza - primary care reporting (VIPER): an observational study to assess the effectiveness of the pandemic influenza A (H1N1)v vaccine.
Effectiveness of pandemic and seasonal influenza vaccine in preventing pandemic influenza A(H1N1)2009 infection in England and Scotland 2009-2010.
Reflections on Pandemic (H1N1) 2009 and the International Response
Problemática de la vacunación contra la gripe A en España
Preparing for influenza after 2009 H1N1: special considerations for pregnant women and newborns.
Efficacy Studies of Influenza Vaccines: Effect of End Points Used and Characteristics of Vaccine Failures.
Prevención de la gripe en mayores
Vigilancia de la gripe en Europa ECDC
Vigilancia de la gripe en España
Campaña vacunal frente a Gripe A. Opiniones sobre la inmunización entre el Colectivo Médico
Systematic review of interventions to increase influenza vaccination rates of those 60 years and older.
Vaccines for preventing influenza in the elderly.
Influenza vaccination for healthcare workers who work with the elderly
New interventions to increase influenza vaccination rates in health care workers.
RESULTADOS Y LECCIONES APRENDIDAS DURANTE LA PANDEMIA DE GRIPE (H1N1) 2009 A

PAPILOMA VIRUS HUMANO

Human papillomavirus vaccination and social inequality: results from a prospective cohort study.
Considerations for human papillomavirus (HPV) vaccination of mid-adult women in the United States.
Major clinical research advances in gynecologic cancer in 2010.
Human papillomavirus vaccination in males: the state of the science.
Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women.
Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial.
Efficacy and Safety of Prophylactic Vaccines against Cervical HPV Infection and Diseases among Women: A Systematic Review & Meta-Analysis.
Efficacy of human papillomavirus vaccines: a systematic quantitative review.
Evaluation of quadrivalent HPV 6/11/16/18 vaccine efficacy against cervical and anogenital disease in subjects with serological evidence of prior vaccine type HPV infection.
Prophylactic Efficacy of a Quadrivalent Human HPV vaccine in women with virological evidence of HPV infection
Integration of human papillomavirus vaccination, cytology, and human papillomavirus testing
Cost-effectiveness of human papillomavirus vaccination and cervical cancer screening in women older than 30 years in the United States.
Considerations for human papillomavirus (HPV) vaccination of mid-adult women in the United States.

HERPES ZOSTER

Herpes zoster vaccination among adults aged 60 years or older in the United States, 2007: uptake of the first new vaccine to target seniors.
Prevention of Herpes Zoster MMWR
Herpes zoster vaccine in older adults and the risk of subsequent herpes zoster disease.

SARAMPION

acute sclerosing panencephalitis in papua new guinean children: the cost of continuing inadequate measles vaccine coverage.
Attitudinal and demographic predictors of measles-mumps-rubella vaccine (MMR) uptake during the UK catch-up campaign 2008-09: cross-sectional survey.
Who gets measles in Europe?
DO EUROPEAN DOCTORS SUPPORT MEASLES, MUMPS, RUBELLA VACCINATION PROGRAMMES ENOUGH?
The MMR vaccine and autism: Sensation, refutation, retraction, and fraud.
Lancet retracts 12-year-old article linking autism to MMR vaccines.
Lack of association between measles-mumps-rubella vaccination and autism in children: a case-control study
Measles, mumps and rubella infections and atopic disorders in MMR-unvaccinated and MMR-vaccinated children.
MMR vaccination and disease elimination: the Finnish experience.
Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: a 20-year follow-up.
Vaccines for measles, mumps and rubella in children.
Vaccination policies for health-care workers in acute health-care facilities in Europe.
Spotlight on measles 2010: Measles elimination in Europe – a new commitment to meet the goal by 2015
Spotlight on measles 2010: An ongoing outbreak of measles in an unvaccinated population in Granada
Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).
Todavía sarampión en España
Situación Epidemiológica. Instituto Carlos III
Todo sobre el sarampión De A. Domínguez

TOSFERINA

Incidence trends in pertussis in the Autonomous Region of Madrid, Spain: 1982-2005.
Combined DTP-HBV-HIB vaccine versus separately administered DTP-HBV and HIB vaccines for primary prevention of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae B (HIB).
Cobertura vacunal en la infancia en familias inmigrantes
Epidemiology of pertussis in a country with high vaccination coverage.
Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women and Persons Who Have or Anticipate Having Close Contact with an Infant Aged <12 Months --- Advisory Committee on Immunization Practices (ACIP), 2011.
Tosferina: revisión, situación epidemiológica y recomendaciones
Situación tos ferina España

Comunicación y vacunas

Use of multimedia as an educational tool to improve human papillomavirus vaccine acceptability--a pilot study.
Vaccine refusal and the risks of vaccine-preventable diseases.
From the struggle for freedom to the denial of evidence: history of the anti-vaccination movements in Europe
Association between health care providers' influence on parents who have concerns about vaccine safety and vaccination coverage.
A public-professional web-bridge for vaccines and vaccination: User concerns about vaccine safety.
Registros vacunales informatizados respecto a los tradicionales en papel: ¿aportan una mejor calidad?
Physician Communication: Barriers to Achieving Shared Understanding and Shared Decision Making with Patients
Assessing and Responding in Real Time to Online Anti-vaccine Sentiment during a Flu Pandemic
Autism and the Measles, Mumps, and Rubella Vaccine: Need to Communicate a Health Study Retraction to Patients
Differences in attitudes, beliefs and knowledge of hospital health care workers and community doctors to vaccination of older people.
Knowledge of Spanish parents about their children's vaccinations during the decade 1993-2003.
Tracking parental attitudes on vaccination across European countries: The Vaccine Safety, Attitudes, Training and Communication Project (VACSATC).
Content of text messaging immunization reminders: What low-income parents want to know.
Civil society: a critical new advocate for vaccination in Europe.
VACSATC (Seguridad vacunal: actitudes, formación y comunicación): ¿Por qué un proyecto así?
¿Vacunas contra la información o informados para la vacunación?

Tema Etéreo. Con la tecnología de Blogger.